UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

Annals of oncology, 2012-10, Vol.23 (10), p.2578-2584

2012

Volltextzugriff (PDF)

A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative

Annals of oncology, 2013-01, Vol.24 (1), p.47-53

2013

Volltextzugriff (PDF)

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers

Annals of oncology, 2013-07, Vol.24 (7), p.1847-1852

2013

Volltextzugriff (PDF)

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.189-196

2018

Volltextzugriff (PDF)

Different outcome variables yield different results

Annals of oncology, 2013-02, Vol.24 (2), p.554-554

2013

Volltextzugriff (PDF)

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.429-435

2011

Volltextzugriff (PDF)

Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data

Breast (Edinburgh), 2014-08, Vol.23 (4), p.371-377

2014

Volltextzugriff (PDF)

The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers

Breast (Edinburgh), 2013-06, Vol.22 (3), p.254-262

2013

Volltextzugriff (PDF)

342 Prognostic Implications of Invasive Lobular Breast Cancer

European journal of cancer (1990), 2012-03, Vol.48, p.S142-S142

2012

Volltextzugriff (PDF)

Update on triple-negative breast cancer: prognosis and management strategies

International journal of women's health, 2012-01, Vol.4 (default), p.511-520

2012

Volltextzugriff (PDF)

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency

Carcinogenesis (New York), 2012-07, Vol.33 (7), p.1319-1326

2012

Volltextzugriff (PDF)

The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

European journal of cancer (1990), 2018-04, Vol.92, p.S141

2018

Volltextzugriff (PDF)

483 (PB-116) - The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

European journal of cancer (1990), 2018-04, Vol.92, p.S141-S141

2018

Volltextzugriff (PDF)

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi

Pathology Research International, 2010-12, Vol.2011 (2011), p.908-914

2010

Volltextzugriff (PDF)

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

Breast cancer research : BCR, 2017-11, Vol.19 (1), p.119-119, Article 119

2017

Volltextzugriff (PDF)

0139 Why 28% of ER-negative/PR-negative breast cancer (BC) patients did not get chemotherapy (CT)

Breast (Edinburgh), 2009, Vol.18, p.S53-S53

2009

Volltextzugriff (PDF)

Abstract P6-09-11: Independent prognostic value of age depends on breast cancer subtype

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-09-11

2016

Volltextzugriff (PDF)

Abstract P6-10-06: The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-10-06

2016

Volltextzugriff (PDF)

Abstract P6-07-04: Evaluation of Adjuvant! Online for primary operable grade 2 breast cancers with 10-year follow-up

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-04

2012

Volltextzugriff (PDF)

Abstract P6-07-19: Prognostic relevance of PR and detection mode in Luminal Her-2 negative breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-07-19

2012

Volltextzugriff (PDF)

Abstract P5-18-19: The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years later

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-18-19

2012

Volltextzugriff (PDF)

Abstract PD2-3: High body mass index (BMI) and worse response to neoadjuvant chemotherapy (NACT) by breast cancer phenotype: Own data and external validation on German breast group (GBG) patients

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.PD2-3-PD2-3

2013

Volltextzugriff (PDF)

Abstract OT3-2-04: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT3-2-04-OT3-2-04

2013

Volltextzugriff (PDF)

Improved NPI for breast cancer prognosis

European journal of cancer supplements, 2008, Vol.6 (7), p.190-190

2008

Volltextzugriff (PDF)

Different outcome variables yield different results

Annals of oncology, 2013-02, Vol.24 (2), p.554

2013

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(50)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(15)
Humans
(12)
Breast Cancer
(11)
Oncology
(11)
Biological And Medical Sciences
(9)
Female
(9)
Middle Aged
(8)
Prognosis
(8)
Medical Sciences
(7)
Breast Neoplasms - Pathology
(6)
Tumors
(6)
Gynecology. Andrology. Obstetrics
(5)
Hematology, Oncology And Palliative Medicine
(5)
Mammary Gland Diseases
(5)
Aged
(4)
Adult
(3)
Antineoplastic Agents
(3)
Breast Neoplasms - Diagnosis
(3)
Breast Neoplasms - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study

Different outcome variables yield different results

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients

Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data

The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers

342 Prognostic Implications of Invasive Lobular Breast Cancer

Update on triple-negative breast cancer: prognosis and management strategies

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency

The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

483 (PB-116) - The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

0139 Why 28% of ER-negative/PR-negative breast cancer (BC) patients did not get chemotherapy (CT)

Abstract P6-09-11: Independent prognostic value of age depends on breast cancer subtype

Abstract P6-10-06: The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype

Abstract P6-07-04: Evaluation of Adjuvant! Online for primary operable grade 2 breast cancers with 10-year follow-up

Abstract P6-07-19: Prognostic relevance of PR and detection mode in Luminal Her-2 negative breast cancer

Abstract P5-18-19: The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years later

Abstract PD2-3: High body mass index (BMI) and worse response to neoadjuvant chemotherapy (NACT) by breast cancer phenotype: Own data and external validation on German breast group (GBG) patients

Abstract OT3-2-04: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial

Improved NPI for breast cancer prognosis

Different outcome variables yield different results

Suchergebnisse filtern